New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 12, 2014
09:25 EDTIPXL, PRGOPerrigo announces FDA approval of generic version of Astepro nasal spray
Perrigo (PRGO) announced that it has received final approval from the FDA on its Abbreviated New Drug Application for azelastine hydrochloride nasal spray. The ANDA involved contributions from both Perrigo and Impax Laboratories (IPXL), who will share certain costs and benefits of this product. Perrigo and Impax continue to be in first to file Hatch Waxman patent litigation with Meda Pharmaceuticals in the United States District Court for the District of New Jersey. Perrigo has commenced shipment of product to its customers. Annual sales were approximately $97M annually, as measured by Symphony Health Solutions.
News For PRGO;IPXL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 30, 2015
10:57 EDTPRGOPerrigo completes acquisition of Omega Pharma for EUR3.8B
Subscribe for More Information
March 27, 2015
11:33 EDTPRGOPerrigo management to meet with Jefferies
Subscribe for More Information
07:45 EDTPRGOFDA to hold a public meeting
Subscribe for More Information
March 26, 2015
07:30 EDTPRGODeutsche Bank to hold a conference
Pharma One-on-One Day is being held in Denver, Colorado on March 26.
March 23, 2015
10:00 EDTPRGOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:25 EDTPRGOPerrigo downgraded to Sector Perform from Outperform at RBC Capital

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use